Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: A prospective 1-year follow-up study

Journal of Anxiety Disorders

Volumn 25, Issue 7, 2011, Pages 939-945

  Anand, Nitin ^a   Sudhir, Paulomi M ^a   Math, Suresh Bada ^a   Thennarasu, K ^a   Janardhan Reddy, Y C ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Cognitive behavior therapy; Obsessive compulsive disorder; SRI non response

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CLOMIPRAMINE; LITHIUM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DYSTHYMIA; FEMALE; GLOBAL ASSESSMENT FUNCTIONING; HUMAN; LOW DRUG DOSE; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PREDICTION; QUALITY OF LIFE; REMISSION; STATE TRAIT ANXIETY INVENTORY; TREATMENT OUTCOME; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION QUALITY OF LIFE BRIEF VERSION; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

ADULT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 79961021526     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2011.05.007     Document Type: Article

References (52)

1. Abramowitz J.S. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. Journal of Consulting and Clinical Psychology 1997, 65:44-52.
2. Abramowitz J.S. The Psychological treatment of obsessive-compulsive disorder. Canadian Journal of Psychiatry 2006, 51:407-416.
3. Ackerman D.L., Greenland S., Morgenstern H., Bystritsky A. Predictors of treatment response in obsessive compulsive disorder: Multivariate analyses from a multicenter trial of clomipramine. Journal of Clinical Psychopharmacology 1994, 14:247-254.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. Fourth ed.
5. Dew M.A., Switzer G.E., Myaskovsky L., Dimartini A.F., Tovt-Korshynska M.I. Rating scales for mood disorders. Textbook of mood disorders 2006, 69-97. American Psychiatric Publishing Inc., Arlington, VA. D.J. Stein, D.J. Kupfer, A.F. Schatzberg (Eds.).
6. Eddy K.T., Dutra L., Bradley R., Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clinical Psychology Review 2004, 24:1011-1030.
7. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. Global Assessment of Functioning (GAF) scale. Handbook of psychiatric measures 2010, 86-90. American Psychiatric Publishing, New Delhi. 2nd ed. J. Rush, M.B. First, D. Blacker (Eds.).
8. First M.B., Spitzer R.L., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I disorders, Patient Edition (SCID-I/P, Version 2.0) 1995, Biometrics Research, New York State Psychiatric Institute, New York.
9. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L.S. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) 1997, American Psychiatric Press, Washington, DC.
10. Fisher P.L., Wells A. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis. Behavior Research Therapy 2005, 43:1543-1558.
11. Foa E.B., Liebowitz M.R., Kozak M.J., Davies S., Campeas R., Franklin M.E., et al. Randomized placebo controlled trial of exposure and ritual prevention, clomipramine and their combination in the treatment of obsessive compulsive disorder. American Journal of Psychiatry 2005, 162:151-161.
12. Gava I., Barbui C., Aguglia E., Churchill R., DeVanna M., McGuire M. Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD). Cochrane Database Systematic Review 2007, 18(2):CD005333.
13. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Delgado P., Heninger G.R. The Yale-Brown Obsessive Compulsive Scale II: validity. Archives of General Psychiatry 1989, 46:1012-1016.
14. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L. The Yale-Brown Obsessive Compulsive Scale I: development, use, and reliability. Archives of General Psychiatry 1989, 46(11):1006-1011.
15. Greist J.H., Jefferson J.W., Kobak K.A., Katzelnik D.J., Serlin R.C. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: a meta analysis. Archives of General Psychiatry 1995, 52:53-60.
16. Guy W. Clinical Global Impressions (CGI) scale. Handbook of psychiatric measures 2010, 90-92. American Psychiatric Publishing, New Delhi. 2nd ed. J. Rush, M.B. First, D. Blacker (Eds.).
17. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare Publication (ADM) 76-338 1976, National Institute of Mental Health, Rockville, MD, pp. 218-222.
18. Horwath E., Weissman M.M. The epidemiology and cross-national presentation of obsessive compulsive disorder. Psychiatric Clinics of North America 2000, 23:493-507.
19. Jacobson N.S., Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991, 59:12-19.
20. Kampman M., Keijsers G.P.J., Hoogduin C.A.L., Verbraak J.P.M. Addition of cognitive behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. Acta Psychiatrica Scandinavia 2002, 106:314-319.
21. Koran L.M., Hanna G.L., Hollander E., Nestadt G. Practice guidelines for the treatment of patients with obsessive compulsive disorder 2007, American Psychiatric Association, Arlington, VA.
22. Kozak M.J., Foa E.B. Mastery of obsessive compulsive disorder: a cognitive behavioural approach-therapist guide 1997, The Psychological Corporation, San Antonio, TX.
23. Kozak M.U., Liebowitz M.L., Foa E.B. Cognitive behavior therapy and pharmacotherapy for OCD. Obsessive-compulsive disorder 2000, 501-523. Lawrence Erlbaum Associates, Mahwah, NJ. W.K. Goodman, M. Rudorfer, J.D. Maser (Eds.).
24. Lobbestael, J., Leurgans, M., & Arntz, A. (2010). Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II). Clinical Psychology and Psychotherapy (March 21).
25. Mancebo M.C., Eisen J.L., Pinto A., Geenberg B.D., Dyck I.R., Rasmussen S.A. The Brown Longitudinal Obsessive Compulsive Study: treatments received and patient impressions of improvement. Journal of Clinical Psychiatry 2006, 67:1713-1720.
26. March J.S., Frances A., Carpenter D., Kahn D. The expert consensus guideline series: treatment of obsessive-compulsive disorder. Journal of Clinical Psychiatry 1997, 58(Suppl. 4):3-72.
27. Marks I. Behaviour therapy for obsessive-compulsive disorder: a decade of progress. Canadian Journal of Psychiatry 1997, 42:1021-1027.
28. Miguel E.C., Leckman J.F., Rauch S., do Rosario Compos M.C., Hounie A.G., Mercadante T., et al. Obsessive-compulsive disorder phenotypes: implications for genetic studies. Molecular Psychiatry 2005, 10:258-275.
29. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979, 134:382-389.
30. National Institute for Health and Clinical Excellence. (2005). Obsessive compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder [NICE Guideline]. Clinical guideline No. 31. London, UK: National Institute for Health and Clinical Excellence.
31. Pallanti S., Hollander E., Bienstock C., Koran L., Leckman J., Marazziti D., et al. Treatment non-response in OCD: methodological issues and operational definitions. International Journal Neuro Psychopharmacology 2002, 5:181-191.
32. Pallanti S., Hollander E., Goodman W.K. A qualitative analysis of nonresponse: management of treatment refractory obsessive-compulsive disorder. Journal of Clinical Psychiatry 2004, 65(Suppl. 14):6-10.
33. Patterson D.A., Lee M.S. Field trial of the Global Assessment of Functioning Scale-modified. American Journal of Psychiatry 1995, 152(9):1386-1388.
34. Pigott T.A., Seay S.M. Biological treatments for obsessive-compulsive disorder: literature review. Obsessive-compulsive disorder: theory, research, and treatment 1998, 298-326. Guilford Press, New York, NY. R.P. Swinson, M.M. Antony, S. Rachman, M.A. Richter (Eds.).
35. Pigott T.A., Seay S.M. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Journal of Clinical Psychiatry 1999, 60:101-106.
36. Primakoff L., Epstein N., Covi L. Homework compliance: an uncontrolled variable in cognitive therapy outcome research. Behavior Therapy 1986, 17:433-446.
37. Rasmussen S.A., Eisen J.L., Pato M.T. Current issues in pharmacological management of obsessive-compulsive disorder. Journal of Clinical Psychiatry 1993, 54(Suppl.):4-9.
38. Rauch S.L., Jenike M.A. Pharmacological treatment of obsessive compulsive disorder. A guide to treatments that work 1998, 358-376. Oxford University Press, New York, NY. P.E. Nathan, J.M. Gorman (Eds.).
39. Schwartz J.M., Beyette B. Brain lock: free yourself from obsessive compulsive behaviour 1996, Harper Collins, New York.
40. Schwartz J.M. Neuroanatomical aspects of cognitive behavioral therapy response in obsessive-compulsive disorder: an evolving perspective on brain and behavior. British Journal of Psychiatry 1998, 173:38-44.
41. Shetti C.N., Reddy Y.C.J., Kandavel T., Kashyap K., Singisetti S., Hiremath A.S., et al. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. Journal of Clinical Psychiatry 2005, 66:1517-1523.
42. Simpson H.B., Gorfinkle K.S., Liebowitz M. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. Journal of Clinical Psychiatry 1999, 60:584-590.
43. Simpson H.B., Foa E.B., Liebowitz M.R., Ledley D.R., Huppert J.D., Cahill S., et al. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. American Journal of Psychiatry 2008, 165(5):621-630. doi:appi.ajp.2007.07091440 [pii] 10.1176/appi.ajp.2007.07091440.
44. Skevington S.M., Lotfy M., O'Connell K.A. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research 2004, 13(2):299-310.
45. Spielberger C.D., Gorsuch R.L., Lushene R.E. Test manual for state-trait anxiety inventory 1970, Consulting Psychologists Press, Palo Alto, CA.
46. Spielberger C.D., Reheiser E.C. Assessment of emotion: anxiety, anger, depression and curiosity. Applied Psychology: Health and Well-being 2009, 1(3):271-302.
47. Tolin D.F., Hannan S., Maltby N., Diefenbach G.J., Worhunsky P., Brady R.E. A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials. Behavior Therapy 2007, 38:179-191.
48. Tolin D.F., Maltby N., Diefenbach G.J., Hannan S.E., Worhunsky P. Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. Journal of Clinical Psychiatry 2004, 65:922-931.
49. Tundo A., Salvati L., Busto G., Di Spgnio D., Falcini R. Addition of cognitive behavioral therapy for nonresponders to medication for obsessive compulsive disorder: a naturalistic study. Journal of Clinical Psychiatry 2007, 68:1552-1556.
50. Whittal M., Thordarson D., McLean P. Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs. exposure and response prevention. Behavior Research and Therapy 2005, 43:1559-1576.
51. World Health Organization (WHO) WHOQOL-BREF. Introduction, administration, scoring and generic version of the assessment-field trial version 1996, World Health Organization, Geneva.
52. Zanarini M.C., Skodol A.E., Bender D., Dolan R., Sanislow C., Schaefer E., et al. The Collaborative Longitudinal Personality Disorders Study: reliability of axis I and II diagnoses. Journal of Personality Disorders 2000, 14(4):291-299.